Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal

被引:29
|
作者
Buechner, Philipp [1 ]
Hinderer, Marc [1 ]
Unberath, Philipp [1 ]
Metzger, Patrick [2 ,3 ,4 ]
Boeker, Martin [5 ,6 ]
Acker, Till [7 ]
Haller, Florian [8 ]
Mack, Elisabeth [9 ,10 ]
Nowak, Daniel [11 ,12 ]
Paret, Claudia [13 ,14 ]
Schanze, Denny [15 ]
von Bubno, Nikolas [16 ,17 ,18 ]
Wagner, Sebastian [19 ]
Busch, Hauke [20 ,21 ]
Boerries, Melanie [2 ,3 ,22 ,23 ,24 ,25 ]
Christoph, Jan [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Med Informat, D-91058 Erlangen, Germany
[2] Univ Freiburg, Fac Med, Inst Med Bioinformat & Syst Med, D-79110 Freiburg, Germany
[3] Univ Freiburg, Med Ctr, D-79110 Freiburg, Germany
[4] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany
[5] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, D-79104 Freiburg, Germany
[6] Univ Freiburg, Med Ctr, D-79104 Freiburg, Germany
[7] Justus Liebig Univ Giessen, Inst Neuropathol, D-35392 Giessen, Germany
[8] Univ Hosp Erlangen, Inst Pathol, D-91054 Erlangen, Germany
[9] Philipps Univ Marburg, Dept Hematol Oncol & Immunol, Baldingerstr, D-35043 Marburg, Germany
[10] Univ Hosp Giessen & Marburg, Baldingerstr, D-35043 Marburg, Germany
[11] Heidelberg Univ, Med Fac Mannheim, Dept Hematol & Oncol, D-68167 Mannheim, Germany
[12] Heidelberg Univ, Med Fac Mannheim, Heinrich Lanz Ctr Digital Hlth, D-68167 Mannheim, Germany
[13] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Childrens Hosp, Pediat Hematol Oncol, D-55131 Mainz, Germany
[14] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Univ Canc Ctr UCT, D-55131 Mainz, Germany
[15] Otto Von Guericke Univ, Fac Med, Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany
[16] Univ Schleswig Holstein, Dept Hematol & Oncol, Med Ctr, Campus Lubeck, D-23538 Lubeck, Germany
[17] German Canc Consortium DKTK, Partner Site Freiburg, D-79106 Freiburg, Germany
[18] Univ Freiburg, Med Ctr, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany
[19] Goethe Univ Hosp, Dept Med 2, Hematol Oncol, D-60590 Frankfurt, Germany
[20] Univ Lubeck, Inst Expt Dermatol, D-23562 Lubeck, Germany
[21] Univ Lubeck, Inst Cardiogenet, D-23562 Lubeck, Germany
[22] Univ Freiburg, Fac Med, CCCF, D-79106 Freiburg, Germany
[23] Univ Freiburg, Med Ctr, D-79106 Freiburg, Germany
[24] German Canc Consortium DKTK, Partner Site Freiburg, D-69120 Heidelberg, Germany
[25] German Canc Res Ctr, D-69120 Heidelberg, Germany
关键词
decision making; computer-assisted; decision support systems; clinical; precision medicine; computational biology; molecular tumor board; cBioPortal; requirements analysis; neoplasms; EXPERIENCE; GENOMICS;
D O I
10.3390/diagnostics10020093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of genetic high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtain the necessary information. The aim of this work was to gather a comprehensive list of requirements to be met by cBioPortal to support processes in MTBs according to clinical needs. Therefore, oncology experts at nine German university hospitals were surveyed in two rounds of interviews. To generate an interview guideline a scoping review was conducted. For visual support in the second round, screenshot mockups illustrating the requirements from the first round were created. Requirements that cBioPortal already meets were skipped during the second round. In the end, 24 requirements with sometimes several conceivable options were identified and 54 screenshot mockups were created. Some of the identified requirements have already been suggested to the community by other users or are currently being implemented in cBioPortal. This shows, that the results are in line with the needs expressed by various disciplines. According to our findings, cBioPortal has the potential to significantly improve the processes and analyses of an MTB after the implementation of the identified requirements.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Early timing analysis based on scenario requirements and platform models
    Jörg Holtmann
    Julien Deantoni
    Markus Fockel
    Software and Systems Modeling, 2022, 21 (6): : 2171 - 2211
  • [22] Early timing analysis based on scenario requirements and platform models
    Holtmann, Jorg
    Deantoni, Julien
    Fockel, Markus
    SOFTWARE AND SYSTEMS MODELING, 2022, 21 (06): : 2171 - 2211
  • [23] CONCEPT-ACQUISITION AND ANALYSIS FOR REQUIREMENTS SPECIFICATION
    LOUCOPOULOS, P
    CHAMPION, REM
    SOFTWARE ENGINEERING JOURNAL, 1990, 5 (02): : 116 - 124
  • [24] Requirements specification model based on multiple viewpoints
    Xiaoxing Weixing Jisuanji Xitong/Mini-Micro Systems, 2000, 21 (09): : 953 - 957
  • [25] An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis
    Specchia, Maria Lucia
    Di Pilla, Andrea
    Gambacorta, Maria Antonietta
    Filippella, Alessandro
    Beccia, Flavia
    Farina, Sara
    Meldolesi, Elisa
    Lanza, Chiara
    Bellantone, Rocco Domenico Alfonso
    Valentini, Vincenzo
    Tortora, Giampaolo
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [26] RULE-BASED REQUIREMENTS SPECIFICATION AND VALIDATION
    TSALGATIDOU, A
    KARAKOSTAS, V
    LOUCOPOULOS, P
    LECTURE NOTES IN COMPUTER SCIENCE, 1990, 436 : 251 - 263
  • [27] Enterprise model based specification of functional requirements
    Lopata, Audrius
    Gudas, Saulius
    INFORMATION TECHNOLOGIES' 2008, PROCEEDINGS, 2008, : 189 - 194
  • [28] Domain Modeling Based on Requirements Specification and Ontology
    Dubielewicz, Iwona
    Hnatkowska, Bogumila
    Huzar, Zbigniew
    Tuzinkiewicz, Lech
    SOFTWARE ENGINEERING: CHALLENGES AND SOLUTIONS, 2017, 504
  • [29] Carcinoma of unknown primary: Molecular tumor board-based therapy
    Shreenivas, Aditya, V
    Kato, Shumei
    Hu, Jingjing
    Skefos, Catherine
    Sicklick, Jason
    Kurzrock, Razelle
    CA-A CANCER JOURNAL FOR CLINICIANS, 2022, 72 (06) : 510 - 523
  • [30] Integration of proteomics in the molecular tumor board
    Thiery, Johanna
    Fahrner, Matthias
    PROTEOMICS, 2024, 24 (12-13)